Old Web
English
Sign In
Acemap
>
Paper
>
and FCGR3A chemoimmunotherapy in the PRIMA study is not affected by Clinical outcome of patients with follicular lymphoma receiving
and FCGR3A chemoimmunotherapy in the PRIMA study is not affected by Clinical outcome of patients with follicular lymphoma receiving
2014
Peggy Dartigues
Gilles Salles
O. Casasnovas
John Catalano
Alain Delmer
Fabrice Jardin
Aurélie Verney
Aurore Perrot
Pauline Brice
Réda Bouabdallah
Anne Sonet
G. Cartron
John F Seymour
Marie-Hélène Delfau-Larue
Keywords:
Follicular lymphoma
Chemoimmunotherapy
Pathology
Medicine
Oncology
Internal medicine
FCGR3A
Correction
Cite
Save
Machine Reading By IdeaReader
45
References
0
Citations
NaN
KQI
[]